Ticker

No recent analyst price targets found for RMTG.

Latest News for RMTG

RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America

Cellgenic Launches Regulated Commercial Operations in Argentina, Creating a Platform for Biologics Distribution, Physician Education, and Regional Expansion Across Latin America MIAMI, FL / ACCESS Newswire / July 23, 2026 / Regenerative Medical Technologies Group,Inc. (OTCID:RMTG) ("RMTG" or the "Company"), throughits wholly owned subsidiary Global Stem Cells Group and its commercial division Cellgenic, today…

Accesswire • Jul 23, 2026
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure

New AI Platform Builds on a 30+ Country Physician Network and the ISSCA Mobile App to Create a Connected, Technology-Enabled Ecosystem for Regenerative and Longevity Medicine MIAMI, FL / ACCESS Newswire / June 23, 2026 / Regenerative Medical Technologies Group, Inc. (the "Company" or "RMTG") (OTC PINK:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today…

Accesswire • Jun 23, 2026
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine

New physician-facing platform digitizes a 30+ country network and lays the foundation for ISSCA AI™, positioning RMTG at the intersection of regenerative medicine and scalable health technology MIAMI, FL / ACCESS Newswire / June 17, 2026 / Global Stem Cells Group, operating under Regenerative Medical Technologies Group, Inc. (OTCID:RMTG) (the "Company"), today announced the launch of the ISSCA Mobile App - a…

Accesswire • Jun 17, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for RMTG.

No House trades found for RMTG.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top